Labcorp Reports Strong Q4 & Full-Year 2025 Results, Provides Positive 2026 Guidance
LH sits 35% above its 52-week low of $209.375.
Summary
Labcorp announced strong Q4 and full-year 2025 financial results with double-digit adjusted EPS growth, alongside positive 2026 guidance for revenue, adjusted EPS, and free cash flow, supported by strategic investments and share repurchases.
Key Events · Earnings and Guidance · LH
-
Strong 2025 Financial Performance
Labcorp reported Q4 2025 revenue of $3.52 billion (up 5.6% year-over-year) and full-year revenue of $13.95 billion (up 7.2%). Adjusted EPS grew 18.0% in Q4 to $4.07 and 12.8% for the full year to $16.44.
-
Positive 2026 Guidance Issued
The company provided 2026 full-year guidance, projecting revenue between $14.61 billion and $14.79 billion (midpoint growth of 5.4%), adjusted EPS of $17.55 to $18.25 (midpoint growth of 8.9%), and free cash flow of $1.24 billion to $1.36 billion (midpoint growth of 7.8%).
-
Strategic Growth Initiatives
Labcorp expanded partnerships with 13 health systems and laboratories in 2025, launched over 130 new tests, and announced a strategic investment to build a new 500,000 square foot Central Laboratory facility in Indiana.
-
Capital Allocation and Shareholder Returns
The company repurchased $225 million of common stock in Q4 2025, totaling $450 million for the full year, and declared a quarterly cash dividend of $0.72 per share.
Analysis · LH · Industrial Applications And Services
Labcorp Holdings Inc. delivered robust financial performance for both the fourth quarter and full year 2025, exceeding prior year results across key metrics like revenue and adjusted EPS. The company's 2026 guidance projects continued growth, reinforcing a positive outlook. Strategic initiatives, including expanding partnerships, launching innovative new tests, and a significant investment in a new Central Laboratory facility, underscore the company's commitment to future growth and market leadership. The substantial share repurchase program further signals confidence in the company's valuation and commitment to shareholder returns.
At the time of this filing, LH was trading at $282.63 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $23.4B. The 52-week trading range was $209.38 to $293.72. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.